Infectious Disease Doctor: Ravi Durvasula, MD | Loyola Medicine

UPDATE: Loyola Medicine outpatient clinics at River Forest and Elmhurst are without power today, August 12, 2020, due to storms. Patients with appointments at these locations today will receive a phone call to reschedule, or be accommodated at other locations or through a Telehealth visit. We apologize for any inconvenience.

COVID-19 (Coronavirus) Update: Learn More About Loyola Medicine Care During COVID-19.

Ravi Durvasula, MD

Ravi Durvasula, MD


Infectious Disease

Languages Spoken


Clinical Expertise

  • Clostridium Difficile (C. Diff.)
  • Endocarditis
  • Heart Infection
  • Joint Infection
  • Osteomyelitis
  • Parasitic Infections
  • Prosthetic Joint Infection
  • Travel-related Infection
  • Tuberculosis (TB)

About Dr. Durvasula

Sports, Gardening

Medical Education

Medical School
McGill University, Canada
Baylor University College of Medicine - Internal Medicine
  • Yale University School of Medicine - Infectious Diseases

Board Certification

American Board of Internal Medicine
Infectious Disease, American Board of Internal Medicine Subspecialty


  • A paratransgenic strategy to block transmission of Xylella fastidiosa from the glassy-winged sharpshooter Homalodisca vitripennis. Arora, AK; Pesko, KN; Quintero-Hern?ndez, V; Possani, LD; Miller, TA; Durvasula, RV, BMC biotechnology
  • Antiplasmodial activity of hydroxyethylamine analogs: Synthesis biological activity and structure activity relationship of plasmepsin inhibitors., Kumar Singh; Rajendran; Singh; Kumar; Kumar; Singh; Miller; Potemkin; Poonam; Grishina; Gupta; Kempaiah; Durvasula; Singh; Dunn; Rathi, Bioorganic & medicinal chemistry
  • Characterization of a promoter for heterologous protein production. Ogaugwu, CE; Cheng, Q; Fieck, A; Hurwitz, I; Durvasula, R, Biotechnology reports (Amsterdam, Netherlands)
View All ResearchShow Less
  • An integrated overview of the midgut bacterial flora composition of Phlebotomus perniciosus a vector of zoonotic visceral leishmaniasis in the Western Mediterranean Basin., Fraihi, W; Fares, W; Perrin, P; Dorkeld, F; Sereno, D; Barhoumi, W; Sbissi, I; Cherni, S; Chelbi, I; Durvasula, R; Ramalho-Ortigao, M; Gtari, M; Zhioua, E, PLoS neglected tropical diseases
  • Measuring Success in Global Health Training: Data From 14 Years of a Postdoctoral Fellowship in Infectious Diseases and Tropical Medicine. Tucker, JD; Hughes, MA; Durvasula, RV; Vinetz, JM; McGovern, VP; Schultz, R; Dunavan, CP; Wilson, ME; Milner, DA; LaRocque, RC; Calderwood, SB; Guerrant, RL; Weller, PF; Taylor, TE, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • A delivery system for field application of paratransgenic control. Arora, AK; Forshaw, A; Miller, TA; Durvasula, R, BMC biotechnology
  • Aerobic bacterial flora of biotic and abiotic compartments of a hyperendemic Zoonotic Cutaneous Leishmaniasis (ZCL) focus. Maleki-Ravasan, N; Oshaghi, MA; Afshar, D; Arandian, MH; Hajikhani, S; Akhavan, AA; Yakhchali, B; Shirazi, MH; Rassi, Y; Jafari, R; Aminian, K; Fazeli-Varzaneh, RA; Durvasula, R, Parasites & vectors
  • Bacterial Infection and Immune Responses in Lutzomyia longipalpis Sand Fly Larvae Midgut. Heerman, M; Weng, JL; Hurwitz, I; Durvasula, R; Ramalho-Ortigao, M, PLoS neglected tropical diseases
  • Streptokinase-A Drug for Thrombolytic Therapy: A Patent Review. Kunamneni, A; Durvasula, R, Recent advances in cardiovascular drug discovery
  • Taking a bite out of mosquitoes: a new drug to block transmission of malaria. Durvasula, R, The Journal of infectious diseases